Clinical Trials for Adult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL)

Find clinical trials for adult patients with newly diagnosed or relapsed or refractory primary central nervous system lymphoma (pcnsl). Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)

NCT ID: NCT02315326

This clinical trial is studying a medication called ibrutinib (also known as Imbruvica™) to see how well it works when added to standard chemotherapy for patients with certain types of brain lympho...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Commack, New York, United States +15 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions